In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

On Medindia find the complete list of Growth Hormone drugs with their available forms and strength. More information is available on each drug including their price list. We recommend consulting ...

In April, 1985, the FDA banned the distribution of pituitary growth hormone (hGH) because of the possibility that it was contaminated by a “slow virus”. All parents of children receiving hGH ...

chuv.ch Background and objectives: Recombinant human growth hormone (rhGH) has been on the list of forbidden substances since availability ... 19– 21 GH has been considered as an ergogenic drug since ...

The Global Endocrinology Drugs Market was valued at approximately USD 25,084.24 million in 2022 and is projected to grow at a robust CAGR of more than 7.82% during the forecast period from 2023 to ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

The global human growth hormone market size was valued at USD 6.81 billion in 2024 and is projected to reach from USD 7.63 billion in 2025 to USD 18.75 billion by 2033, growing at a CAGR of 11.90% ...

Click on the status to view our full coverage. Lonapegsomatropin-tcgd (Ascendis Pharma) Long-acting growth hormone Treatment of adults with growth hormone deficiency. Supplemental BLA accepted for ...

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.

"The pathway impacts the hormone signalling that drives ... problems we face in treating cancer. Finding drugs that can slow down cancer’s growth when all other treatments have stopped working ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide.